There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Aura Biosciences Inc (AURA – Research Report), Guardant Health (GH – Research Report) and Day One Biopharmaceuticals (DAWN – Research Report) with bullish sentiments.
Aura Biosciences Inc (AURA)
In a report released today, George Farmer from Scotiabank maintained a Buy rating on Aura Biosciences Inc, with a price target of $20.00. The company’s shares closed last Monday at $11.00.
According to TipRanks.com, Farmer is a top 100 analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Aura Biosciences Inc with a $26.33 average price target, which is a 124.9% upside from current levels. In a report released yesterday, BTIG also maintained a Buy rating on the stock with a $38.00 price target.
See today’s best-performing stocks on TipRanks >>
Guardant Health (GH)
Scotiabank analyst Sung Ji Nam reiterated a Buy rating on Guardant Health today and set a price target of $47.00. The company’s shares closed last Monday at $27.74.
According to TipRanks.com, Nam is a 1-star analyst with an average return of
Guardant Health has an analyst consensus of Strong Buy, with a price target consensus of $46.82, a 65.0% upside from current levels. In a report released yesterday, Canaccord Genuity also maintained a Buy rating on the stock with a $60.00 price target.
Day One Biopharmaceuticals (DAWN)
JonesTrading analyst Soumit Roy maintained a Buy rating on Day One Biopharmaceuticals today and set a price target of $45.00. The company’s shares closed last Monday at $12.19, close to its 52-week low of $9.67.
According to TipRanks.com, Roy has 0 stars on 0-5 stars ranking scale with an average return of
Currently, the analyst consensus on Day One Biopharmaceuticals is a Moderate Buy with an average price target of $38.50, a 201.5% upside from current levels. In a report issued on October 30, H.C. Wainwright also maintained a Buy rating on the stock with a $50.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on AURA:
